- Home
- BLIV vs LVTX Comparison
BLIV vs LVTX Comparison
Compare BLIV & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIV
- LVTX
- Stock Information
- Founded
- BLIV 2014
- LVTX 2016
- Country
- BLIV Singapore
- LVTX Netherlands
- Employees
- BLIV N/A
- LVTX N/A
- Industry
- BLIV
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- BLIV
- LVTX Health Care
- Exchange
- BLIV NYSE
- LVTX Nasdaq
- Market Cap
- BLIV 39.8M
- LVTX 33.9M
- IPO Year
- BLIV 2025
- LVTX 2021
- Fundamental
- Price
- BLIV $3.79
- LVTX $1.31
- Analyst Decision
- BLIV
- LVTX Hold
- Analyst Count
- BLIV 0
- LVTX 3
- Target Price
- BLIV N/A
- LVTX $1.75
- AVG Volume (30 Days)
- BLIV 68.2K
- LVTX 39.1K
- Earning Date
- BLIV 01-01-0001
- LVTX 08-19-2025
- Dividend Yield
- BLIV N/A
- LVTX N/A
- EPS Growth
- BLIV N/A
- LVTX N/A
- EPS
- BLIV N/A
- LVTX N/A
- Revenue
- BLIV $1,355,200.00
- LVTX $4,990,000.00
- Revenue This Year
- BLIV N/A
- LVTX N/A
- Revenue Next Year
- BLIV N/A
- LVTX N/A
- P/E Ratio
- BLIV N/A
- LVTX N/A
- Revenue Growth
- BLIV N/A
- LVTX N/A
- 52 Week Low
- BLIV $2.69
- LVTX $0.85
- 52 Week High
- BLIV $6.40
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- BLIV N/A
- LVTX 51.02
- Support Level
- BLIV N/A
- LVTX $1.28
- Resistance Level
- BLIV N/A
- LVTX $1.40
- Average True Range (ATR)
- BLIV 0.00
- LVTX 0.05
- MACD
- BLIV 0.00
- LVTX -0.00
- Stochastic Oscillator
- BLIV 0.00
- LVTX 52.63
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.